Share on StockTwits

LeMaitre Vascular (NASDAQ:LMAT) declared a quarterly dividend on Thursday, July 31st, AR Network reports. Investors of record on Thursday, August 21st will be given a dividend of 0.035 per share on Thursday, September 4th. This represents a $0.14 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date of this dividend is Tuesday, August 19th.

LMAT has been the subject of a number of recent research reports. Analysts at Stifel Nicolaus initiated coverage on shares of LeMaitre Vascular in a research note on Tuesday, June 24th. They set a “buy” rating and a $11.00 price target on the stock. Finally, analysts at Brean Capital initiated coverage on shares of LeMaitre Vascular in a research note on Monday, May 19th. They set a “buy” rating and a $11.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. LeMaitre Vascular currently has an average rating of “Buy” and a consensus price target of $10.47.

Shares of LeMaitre Vascular (NASDAQ:LMAT) traded up 0.25% on Thursday, hitting $8.11. 10,941 shares of the company’s stock traded hands. LeMaitre Vascular has a 52 week low of $6.39 and a 52 week high of $8.96. The stock has a 50-day moving average of $7.76 and a 200-day moving average of $7.90. The company has a market cap of $130.7 million and a P/E ratio of 50.56.

LeMaitre Vascular (NASDAQ:LMAT) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. The company had revenue of $18.20 million for the quarter, compared to the consensus estimate of $17.50 million. On average, analysts predict that LeMaitre Vascular will post $0.23 earnings per share for the current fiscal year.

LeMaitre Vascular, Inc (NASDAQ:LMAT) is a global provider of medical devices and implants for the treatment of peripheral vascular disease.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.